Logo

Shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER10693IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE20.00 €
 Subtotal 20.00 €